TrialSignal
Clinical trial intelligence report
Effect of Raloxifene on Ovulation in Women With Polycystic Ovarian Syndrome.
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 20, 2026
NCT ID
NCT01607320
Status
TERMINATED
Phase
NA
Sponsor
Bruce Lessey
Executive brief
Investment-Ready Snapshot
Effect of Raloxifene on Ovulation in Women With Polycystic Ovarian Syndrome. is a NA clinical asset sponsored by Bruce Lessey in Polycystic Ovarian Syndrome. SEO and diligence focus: Raloxifene, Clomiphene, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT01607320
Indication
Polycystic Ovarian Syndrome
Modality
small molecule
Target
Raloxifene, Clomiphene
Intervention
Raloxifene, Clomiphene
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.